Home Bellerophon Therapeutics

Bellerophon Therapeutics

Out of service
IPO Delisting
Drug Delivery Device Developer
Basic
Enterprise Profile

Basic Information

Bellerophon Therapeutics is a clinical-stage biotherapeutics company dedicated to developing innovative products that combine novel drugs and devices for the treatment of cardiopulmonary and heart diseases. Our mission is to develop molecular systems through innovative research, conducting in-depth studies on molecules to treat diseases with significant clinical needs.
Bellerophon Therapeutics, Inc.
NewJersey,United States of America
15~50 people
January 01, 2009
--

Enterprise Profile

Industrial Sector
Medical Device R&D and Design Therapeutic Manufacturing
Concept
Cardiovascular Disease
Application Scenarios
Medical Equipment